68.5% of technology-dependent infants experience delayed hospital discharge — average delays of 53 to 90 days, $450,000 in avoidable cost per child — not because the patients aren't medically ready, but because the home care infrastructure required to receive them doesn't exist at Medicaid rates. OBBBA cuts are about to make both sides of this problem worse simultaneously. The market to fix it is mostly white space.
The capital and the policy are moving in opposite directions. Investors put $210M into the country's largest telepsychiatry platform the same quarter HHS announced a federal posture shift warning against the medication-management models that underpin much of the category. A $9.5M seed went into pediatric specialty care coordination as Rock Health confirmed Q1 2026 average deal sizes hit their highest point since Q4 2021 — driven by megadeals in categories that are not maternal-pediatric health.
Nebraska becomes the country's OBBBA test case as Medicaid work requirements take effect, North Carolina proposes the first major 2026 state ABA policy crackdown, Florida's 42,000 KidCare-eligible children are still waiting, Aveanna's $175.5M Family First Homecare acquisition lands as the largest pediatric PDN deal of the year, and Carrot keeps building its postpartum-to-pediatric employer benefits stack.
US digital health closed 2025 with $14.2B in venture funding, yet pediatric companies still receive a single-digit share. Five structural mechanisms — Medicaid-dominant payer mix, regulatory complexity, evidence economics, fragmented reimbursement, and capital concentration — compound against pediatric pure-plays. The viable pediatric digital health business in 2026 is increasingly not a pediatric digital health business.
A majority of U.S. states now cover doulas under Medicaid. Plus: WIN's PE acquisition by Invidia Capital, Virginia's Momnibus, Montana's 21-day reversal, and what the dual Medicaid+employer pathway means for Flourish Care, Malama Health, and Partum Health.
Montana's Medicaid doula halt is the first documented rollback from a benefit that crossed into mainstream adoption. States are sorting into Defenders, Drifters, and Cutters — and that geography is now a business model variable for every maternal health company with Medicaid exposure.
PE consolidation in pediatric therapy, ONTO Health's $20M Series A with a GCC expansion angle, Sibel Health's Gates Foundation grant and FDA clearance, Trayt Health's statewide Arizona psychiatry access deployment, and a Georgetown report putting numbers on the public funding floor this market depends on.
Natus Sensory acquired Keriton and TheraB Medical in 14 days. AngelEye Health acquired SupportSpot 44 days later. Three NICU deals in one quarter are rewriting the vendor consolidation logic for neonatal care — and compressing the window for everyone still building independently.
The capital keeps flowing into maternal and pediatric health, but this week's pattern shows something specific: investors are sorting into bets that don't depend on Medicaid staying intact. A portable individual fertility insurance product, a school-embedded mental health platform, and an employer maternity program publishing outcome data that moves actuaries.
The doula category raised $30M+ in a single quarter on the strength of Medicaid reimbursement momentum. October 2026 brings the most significant federal threat to that foundation in a decade. The companies that saw it coming built an employer channel. The ones that didn't are now racing a political clock they can't control.
The doula category crossed two thresholds this week: institutional legitimacy and mainstream payer adoption. Partum Health launched 24/7 hospital-embedded doulas at UChicago Medicine while UnitedHealthcare extends benefits to 7.2M employer members — and why maximum policy risk arrived at the same moment.